Related Experiment Video
Updated: Feb 4, 2026
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Insulin-like growth factor 1 (IGF-1)-induced changes in cardiac inducible nitric oxide synthase (iNOS) in obese rats
Sonja Zafirovic1, Milan Obradovic1, Katarina Banjac1
1Department of Radiobiology and Molecular Genetics, VINČA Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Introduction:
The role of insulin-like growth factor 1 (IGF-1) in preserving cardiovascular (CV) health, a well-established fact, cannot be overstated. IGF-1 affects inducible nitric oxide synthase (iNOS) activity, contributing to metabolic homeostasis by promoting insulin and glucose metabolism. Excessive iNOS production is involved in the occurrence and progression of insulin resistance and CV diseases (CVD). This study aimed to assess the in vivo impact of IGF-1 on the activity and gene expression of iNOS in the hearts of obese rats, through the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway.
Methods:
Male adult Wistar rats were fed a standard (Control) or a high-fat (HF) diet for 12 weeks. After the 12th week, half of the Control and HF rats received a single dose of IGF-1 (50 μg/kg, i.p.), while the other half was placebo-treated, and after 24 h the animals were euthanized.
Results:
The in vivo administration of IGF-1 led to a significant increase in nitric oxide (NO), iNOS gene and protein expression, endothelial nitric oxide synthase (eNOS) gene, ERK1/2, and nuclear factor kappa B (NFkB) levels in Control rats. In contrast, HF rats showed a decrease in NO, iNOS protein, and gene, eNOS gene, endothelin-1 and NFkB levels after IGF-1 treatment. Notably, the level of ERK1/2 in HF rats increased following IGF-1 treatment. These results underscore the significant impact of IGF-1 on iNOS activity in obese rat hearts.
Discussion:
Our findings suggest that the treatment of obese rats with IGF-1 could have significant implications for cardiac function, particularly in the context of obesity, by regulating cardiac iNOS.
Related Concept Videos
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
01:28Nitric Oxide Signaling Pathway
02:15SN1 Reaction: Stereochemistry
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
02:05SN1 Reaction: Kinetics
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...
02:25SN1 Reaction: Mechanism
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...
02:42Acidity of 1-Alkynes
The acidic strength of hydrocarbons follows the order: Alkynes > Alkenes > Alkanes. The strength of an acid is commonly expressed in units of pKa — the lower the pKa, the stronger the acid. Among the hydrocarbons, terminal alkynes have lower pKa values and are, therefore, more acidic. For example, the pKa values for ethane, ethene, and acetylene are 51, 44, and 25, respectively, as shown here.